MakeSense PHARMA Hemorrhoidal Relief Cream Recall: CGMP Deviations
Cherry Hill Sales Co. recalls MakeSense PHARMA hemorrhoidal relief cream due to CGMP deviations. Affected products include specific lot numbers and expiration dates. Consumers should contact the manufacturer for details.
Recall notice
CGMP Deviations
Contact the company
What happened, in plain English
Cherry Hill Sales Co. is recalling MakeSense PHARMA hemorrhoidal relief cream because of manufacturing quality control issues. This recall affects specific lot numbers and expiration dates. Consumers should check their product details and contact the manufacturer for instructions. Read more at govinfonow.com/recall/42064-makesense-pharma-hemorrhoidal-relief-cream-recall-cgmp-deviations.
Source Summary by GovInfoNow · govinfonow.com/recall/42064-makesense-pharma-hemorrhoidal-relief-cream-recall-cgmp-deviations · Updated October 8, 2026 · FDA enforcement record: FDA #D-0483-2017
Cite this page
“MakeSense PHARMA Hemorrhoidal Relief Cream Recall: CGMP Deviations.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/42064-makesense-pharma-hemorrhoidal-relief-cream-recall-cgmp-deviations. Based on FDA recall #D-0483-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0483-2017%22&limit=1).
Why it’s dangerous
The product was manufactured with CGMP (Current Good Manufacturing Practices) deviations, which means the quality control process failed. This could lead to inconsistent product quality, but the exact risk to consumers is not specified in the recall notice.
Who’s affected
People who own or use the MakeSense PHARMA hemorrhoidal relief cream with the specific lot numbers and expiration dates listed in the recall. Those with hemorrhoids or related conditions are most at risk.
How to tell if you have this one
Check the product label for the lot numbers #103811 (exp. 09/17) or #105304 (exp. 04/18) and the expiration date. The product is a 1 oz. tube made in China with NDC 69020-205-28.
- Brand
MakeSense PHARMA- Product
MakeSense PHARMA, HEMORRHOIDAL RELIEF CREAM Phenylephrine HCL-0.25% Zinc Oxide-12.50%,1 oz. (28 g) tube, Made in China- Category
Drug
All 5 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Terminated- Distribution
Michigan, Illinois, New York, Florida, Pennsylvania .
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-0483-2017 | MakeSense PHARMA, HEMORRHOIDAL RELIEF CREAM Phenylephrine HCL-0.25% Zinc Oxide-12.50%,1 oz. (28 g) tube, Made in China, Distributed by Cherry Hill Associates, Chesapeake, VA 23320, NDC 69020-205-28; Lot #103811; Exp. 09/17 Lot #105304; Exp. 04/18 NDC 69020-205-28 UPC 857181005108 | 3,600 cartons |
| D-0484-2017 | MakeSense PHARMA FIRST AID CREAM Lidocaine HCL 0.5%, Phenol 0.5%, 1 oz.. (28 g) tube, Made in China, Distributed by Cherry Hill Associates, Chesapeake, VA 23320, NDC 69020-210-28; Lot # 103814; Exp. 09/17 Lot # 105306; Exp. 04/18 NDC 69020-210-28 UPC 85718005139 | 7,200 cartons |
| D-0485-2017 | MakeSense PHARMA Medicated ANTI-ITCH CREAM WITH SOOTHING ALOE VERA AND VITAMIN E, Camphor-1% Menthol-1%, 1oz.(28 g) tube, Made in China, Distributed by Cherry Hill Associates, Chesapeake, VA 23320, NDC 69020-201-28; Lot: 103814; Exp. 08/17 NDC 69020-201-28 UPC 85718005016 | 4,800 cartons |
| D-0486-2017 | MakeSense PHARMA ANTIFUNGAL CREAM 1 oz. Miconazole Nitrate 2%, 1 oz. (28 g) tube, Made in China, Distributed by Cherry Hill Associates, Chesapeake, VA 23320, NDC 69020-208-28; Lot #103810; Exp. 09/17 Lot #105303; Exp. 04/18 NDC 69020-208-28 UPC 857181005092 | 2,400 cartons |
| D-0487-2017 | MakeSense PHARMA ANTIFUNGAL CREAM Clotrimazole 1%, 1.25 oz. (35 g) tube, Made in China, Distributed by Cherry Hill Associates, Chesapeake, VA 23320, NDC 69020-203-35; Lot # 103803; Exp. 08/17 NDC 69020-203-35 UPC 857181005023 | 2,400 cartons |
What to do — step by step
Check Product Details
Look for the lot numbers #103811 (exp. 09/17) or #105304 (exp. 04/18) and the expiration date on the tube.
Where it went and when
Where it was distributed
Distributed in 5 states.
FDA distribution: “Michigan, Illinois, New York, Florida, Pennsylvania .” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Florida, Illinois, Michigan, New York, Pennsylvania.
Recall timeline
FDA terminated this recall 3 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0483-2017 (January 27, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0483-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.